Researchers have shown that not only the ‘where’ and the ‘when’ of long non-coding RNA expression is important for their function, but also the ‘how’.
The transcriptome gives a fuller picture of how genes are expressed. RNA sequencing allows for more detailed information on cellular pathways and expression levels in cancer studies.
Researchers have determined how satellite DNA, considered to be “junk DNA”, plays a crucial role in holding the genome together.
Material left out of common processes for sequencing genetic material in cancer tumours may actually carry important information about why only some people respond to immunotherapy.
Scientists have created a new tool that targets not DNA, but RNA, and used it to correct a protein imbalance in cells from a dementia patient, restoring them to healthy levels.
For previously healthy children, brain infections are rare. But about one out of every 10,000 people who are exposed to common viruses like herpes simplex or influenza will develop a potentially deadly disease, encephalitis.
Skyhawk Therapeutics, focused on the discovery and development of small molecule therapeutics that correct RNA expression, has announced the close of $8 million in seed funding led by major family and biotech investors.